Importantly, we show that MYCN suppresses the clock activators RORα and BMAL1 to sustain cell proliferation and rewire cell metabolism, suggesting that this dysregulation has a functional significance and may contribute to NB oncogenesis. The gene discussed is RORA; the disease is neuroblastoma.